Agios Pharmaceuticals | AGIO - Current Assets

Stock Price
27.85
Daily Change
0.26 0.94%
Monthly
0.11%
Yearly
-9.96%
Q1 Forecast
27.01

Agios Pharmaceuticals reported $942.05M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Agios Pharmaceuticals USD 942.05M 91.06M Dec/2025
Alnylam Pharmaceuticals USD 4.05B 97.85M Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
Arrowhead Research USD 1.17B 223.75M Dec/2025
Astellas Pharma JPY 1.44T 72.43B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Daiichi Sankyo JPY 2.1T 218.5B Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Exelixis USD 1.44B 41.03M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Moderna USD 6.54B 54M Dec/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Puma Biotechnology USD 143.58M 7M Sep/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sarepta Therapeutics USD 2.54B 184.37M Dec/2025
Vertex Pharmaceuticals USD 11.2B 631.4M Dec/2025